Compounded Drugs May Return To Supreme Court After 5th Circuit Backs FDAMA

The Supreme Court could once again be asked to consider FDA's authority over compounded drugs following an appeals court ruling that found the products are considered "new drugs" but are entitled to safe harbor protections under the FDA Modernization Act